Fingerprint
Dive into the research topics of 'Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: A preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically